Medicare Enrolled

Dr. James Maisel, M.D.

Ophthalmology · Hicksville, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
400 SO OYSTER BAY RD, Hicksville, NY 11801
5169396100
In practice since 2006 (19 years)
NPI: 1720009525 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maisel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maisel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maisel

Dr. James Maisel is an ophthalmology specialist in Hicksville, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Maisel performed 80,042 Medicare services across 5,048 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maisel received a total of $26,466 from 20 pharmaceutical and/or device companies across 119 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maisel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 0% volume in NY $26,466 industry payments

Medicare Practice Summary

Medicare Utilization ↗
80,042
Medicare services
Top 0% in NY for ophthalmology
5,048
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,213 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
66,060 $29 $52
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,984 $33 $400
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
2,660 $77 $300
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
2,214 $107 $500
Aflibercept eye injection (Eylea) 1,314 $694 $1,147
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
1,040 $53 $300
Injection, ranibizumab, 0.1 mg 808 $180 $582
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
487 $126 $300
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
453 $111 $250
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
385 $104 $400
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
351 $240 $500
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
287 $1,744 $2,566
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
231 $158 $300
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
223 $51 $600
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
146 $119 $300
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
110 $33 $200
Eye deviation and range of motion exam
An examination to measure eye deviation and assess the range of motion of the eyes.
77 $53 $250
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
49 $32 $400
New patient eye exam, problem focused
A focused examination of the visual system performed during a new patient visit.
43 $76 $200
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
34 $55 $235
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
31 $309 $2,000
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
21 $2,179 $3,500
Extended color vision testing
A comprehensive eye exam that includes specialized tests to evaluate color vision.
18 $47 $200
Retinal and optic nerve function test
A diagnostic test that measures the function of the retina and optic nerve at multiple specific locations.
16 $83 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$26,466
Total received (2018-2024)
Avg $3,781/year across 7 years
Top 6% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
119
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,366 (80.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,100 (19.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,701
2023
$772
2022
$368
2021
$134
2020
$22
2019
$19,241
2018
$2,228

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$2,586
ABBVIE INC.
$332
Regeneron Healthcare Solutions, Inc.
$166
Genentech USA, Inc.
$152
Genentech, Inc.
$125
Bausch & Lomb Americas Inc.
$125
RECORDATI_RARE_DISEASES_INC.
$122
Apellis Pharmaceuticals, Inc.
$92
Top 3 companies account for 83.3% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$14,584
Allergan Inc.
$6,439
Astellas Pharma US Inc
$2,586
Genentech USA, Inc.
$618
ABBVIE INC.
$523
Apellis Pharmaceuticals, Inc.
$283
Johnson & Johnson Surgical Vision, Inc.
$151
Sun Pharmaceutical Industries Inc.
$143
Alcon Laboratories Inc
$125
Genentech, Inc.
$125
Bausch & Lomb Americas Inc.
$125
Aerie Pharmaceuticals, Inc.
$125
RECORDATI_RARE_DISEASES_INC.
$122
Mallinckrodt Enterprises LLC
$119
Kala Pharmaceuticals, Inc.
$119
Coherus Biosciences Inc.
$92
Novartis Pharmaceuticals Corporation
$75
Glaukos Corporation
$71
Mallinckrodt Hospital Products Inc.
$27
Allergan, Inc.
$13
Top 3 companies account for 89.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · BromSite (bromfenac ophthalmic solution) 0.075% · COMBIGAN · CYSTADROPS · Cequa · Cimerli · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · INVELTYS · Izervay · LUMIGAN · Lucentis · MIEBO · OZURDEX · Rhopressa · Susvimo · Syfovre · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · VABYSMO · Vabysmo · iStent inject Trabecular Micro-Bypass Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for ophthalmology in NY.

Looking for an ophthalmology specialist in Hicksville?
Compare ophthalmologists in the Hicksville area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
1,107
Per 100K population
79.7
County median income
$143,408
Nearest hospital
CHSLI ST JOSEPH HOSPITAL
2.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Maisel is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with consulting-driven industry engagement in the top 6% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Maisel experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Maisel performed 66,060 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maisel receive payments from pharmaceutical companies?
Yes. Dr. Maisel received a total of $26,466 from 20 companies across 119 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maisel's costs compare to other ophthalmologists in Hicksville?
Dr. Maisel's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maisel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →